Literature DB >> 36061583

Comprehensive Investigations of Multiple Factors That Are Related to Refractory Outcome in Urosepsis Patients.

Takehiro Sejima1, Toshihiko Masago1, Shuichi Morizane2, Masashi Honda2, Atsushi Takenaka2.   

Abstract

Background: Urosepsis is an acute life-threating disease, and some cases show refractory outcome to therapy. In an aging society of developed countries, characteristics of urosepsis are becoming complicated. We performed a comprehensive investigation regarding the clinical and social aspects that are related to refractory outcomes in urosepsis patients.
Methods: The patient cohort consisted of 66 patients with urosepsis. Multiple factors from clinical and social aspects were reviewed retrospectively. Two categories of refractory outcomes were defined. One was afebrile resistance (AR); fever continued more than 7 days from the initiation of therapy. Another was discharge resistance (DR); hospitalization continued for more than 30 days. Logistic regression analyses were performed to identify significant factors that are related to the AR or DR.
Results: Univariate analysis demonstrated that high score of Eastern Cooperative Oncology Group Performance Status (ECOG PS) (≥ 2) and Age-adjusted Charlson comorbidity index (CCI) (≥ 4), high serum C-reactive protein (CRP) level (≥ 14.9 mg/dL), and low serum albumin level (≤ 2.26 g/dL) were significantly related to AR. Univariate analysis results also revealed that high score of ECOG PS (≥ 2), high serum creatinine level (≥ 1.54 mg/dL) and vasopressor administration were significantly related to DR. Multivariate analyses demonstrated that low serum albumin level (≤ 2.26g/dL) was the only significant factor that was related to AR. In contrast, high score of ECOG PS (≥ 2) and high serum creatinine level (≥ 1.54 mg/dL) were significant factors that were related to DR.
Conclusion: It is suggested that evaluating serum albumin levels is essential for the therapeutic first step because hypoalbuminemia was the significant factor that was related to obstruction to antipyresis. It is also suggested that the deterioration of patients' activities of daily living and renal dysfunction might be the refractory factors for discharge from the hospital, which was the ultimate therapeutic goal. ©2022 Tottori University Medical Press.

Entities:  

Keywords:  sepsis; urinary tract infection; urosepsis

Year:  2022        PMID: 36061583      PMCID: PMC9419220          DOI: 10.33160/yam.2022.08.012

Source DB:  PubMed          Journal:  Yonago Acta Med        ISSN: 0513-5710            Impact factor:   1.371


  31 in total

Review 1.  The role of albumin in critical illness.

Authors:  J P Nicholson; M R Wolmarans; G R Park
Journal:  Br J Anaesth       Date:  2000-10       Impact factor: 9.166

Review 2.  Causes and mechanisms of hypoalbuminaemia.

Authors:  P E Ballmer
Journal:  Clin Nutr       Date:  2001-06       Impact factor: 7.324

3.  Prognostic factors of mortality in patients with community-acquired bloodstream infection with severe sepsis and septic shock.

Authors:  Arturo Artero; Rafael Zaragoza; Juan J Camarena; Susana Sancho; Rosa González; José M Nogueira
Journal:  J Crit Care       Date:  2010-02-10       Impact factor: 3.425

Review 4.  International Society of Nephrology's 0by25 initiative for acute kidney injury (zero preventable deaths by 2025): a human rights case for nephrology.

Authors:  Ravindra L Mehta; Jorge Cerdá; Emmanuel A Burdmann; Marcello Tonelli; Guillermo García-García; Vivekanand Jha; Paweena Susantitaphong; Michael Rocco; Raymond Vanholder; Mehmet Sukru Sever; Dinna Cruz; Bertrand Jaber; Norbert H Lameire; Raúl Lombardi; Andrew Lewington; John Feehally; Fredric Finkelstein; Nathan Levin; Neesh Pannu; Bernadette Thomas; Eliah Aronoff-Spencer; Giuseppe Remuzzi
Journal:  Lancet       Date:  2015-03-13       Impact factor: 79.321

5.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

6.  Outcomes of the Surviving Sepsis Campaign in intensive care units in the USA and Europe: a prospective cohort study.

Authors:  Mitchell M Levy; Antonio Artigas; Gary S Phillips; Andrew Rhodes; Richard Beale; Tiffany Osborn; Jean-Louis Vincent; Sean Townsend; Stanley Lemeshow; R Phillip Dellinger
Journal:  Lancet Infect Dis       Date:  2012-10-26       Impact factor: 25.071

7.  Is albumin a predictor of severity and mortality in patients with abdominal sepsis?

Authors:  Ansony R Godinez-Vidal; Andrew Correa-Montoya; Diana Enríquez-Santos; Sergio U Pérez-Escobedo; Sandra C López-Romero; Noé I Gracida-Mancilla
Journal:  Cir Cir       Date:  2019       Impact factor: 0.361

Review 8.  Targeting C-Reactive Protein in Inflammatory Disease by Preventing Conformational Changes.

Authors:  J R Thiele; J Zeller; H Bannasch; G B Stark; K Peter; S U Eisenhardt
Journal:  Mediators Inflamm       Date:  2015-05-18       Impact factor: 4.711

9.  In-Hospital Death after Septic Shock Reversal: A Retrospective Analysis of In-Hospital Death among Septic Shock Survivors at Thailand's Largest National Tertiary Referral Center.

Authors:  Chairat Permpikul; Chaisith Sivakorn; Surat Tongyoo
Journal:  Am J Trop Med Hyg       Date:  2021-01       Impact factor: 2.345

Review 10.  Raising concerns about the Sepsis-3 definitions.

Authors:  Massimo Sartelli; Yoram Kluger; Luca Ansaloni; Timothy C Hardcastle; Jordi Rello; Richard R Watkins; Matteo Bassetti; Eleni Giamarellou; Federico Coccolini; Fikri M Abu-Zidan; Abdulrashid K Adesunkanmi; Goran Augustin; Gian L Baiocchi; Miklosh Bala; Oussema Baraket; Marcelo A Beltran; Asri Che Jusoh; Zaza Demetrashvili; Belinda De Simone; Hamilton P de Souza; Yunfeng Cui; R Justin Davies; Sameer Dhingra; Jose J Diaz; Salomone Di Saverio; Agron Dogjani; Mutasim M Elmangory; Mushira A Enani; Paula Ferrada; Gustavo P Fraga; Sabrina Frattima; Wagih Ghnnam; Carlos A Gomes; Souha S Kanj; Aleksandar Karamarkovic; Jakub Kenig; Faryal Khamis; Vladimir Khokha; Kaoru Koike; Kenneth Y Y Kok; Arda Isik; Francesco M Labricciosa; Rifat Latifi; Jae G Lee; Andrey Litvin; Gustavo M Machain; Ramiro Manzano-Nunez; Piotr Major; Sanjay Marwah; Michael McFarlane; Ziad A Memish; Cristian Mesina; Ernest E Moore; Frederick A Moore; Noel Naidoo; Ionut Negoi; Richard Ofori-Asenso; Iyiade Olaoye; Carlos A Ordoñez; Mouaqit Ouadii; Ciro Paolillo; Edoardo Picetti; Tadeja Pintar; Alfredo Ponce-de-Leon; Guntars Pupelis; Tarcisio Reis; Boris Sakakushev; Hossein Samadi Kafil; Norio Sato; Jay N Shah; Boonying Siribumrungwong; Peep Talving; Cristian Tranà; Jan Ulrych; Kuo-Ching Yuan; Fausto Catena
Journal:  World J Emerg Surg       Date:  2018-01-25       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.